TABLE 4.
Vaccine | Amt (%) of:
|
|||
---|---|---|---|---|
IL-2 produced by:
|
IFN-γ produced by:
|
|||
CD4+ T cells | CD8+ T cells | CD4+ T cells | CD8+ T cells | |
vP35 | 21 | 79 | 42 | 58 |
vP40 | 35 | 65 | 49 | 51 |
vP35+vP40 | 32 | 68 | 50 | 50 |
vIL-4 | 51 | 49 | 49 | 51 |
dbl-p | 47 | 53 | 53 | 47 |
KOS | 52 | 48 | 51 | 49 |
Mice were immunized with each recombinant virus, and spleens were harvested 3 weeks after the third immunization. Single cell suspensions of CD4+, CD8+, or pooled CD4+ and CD8+ T cells were prepared and subjected to in vitro stimulation for 72 h with 5 PFU of UV-inactivated HSV-1 McKrae/cell. The presence of cytokines in the supernatant was determined by ELISA. Each number represents the percentage of each cytokine that was produced by CD4+ T cells or CD8+ T cells in relation to the amount produced by both T cells from three experiments.